| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5926940 | American Heart Journal | 2014 | 8 Pages |
Abstract
In the year after initiation, adherence to dabigatran for a majority of patients is very good. However, 28% of patients in our cohort had poor adherence. Furthermore, lower adherence to dabigatran was associated with increased adverse outcomes. Concerted efforts are needed to optimize adherence to NOACs.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Supriya MD, Evan P. MS, Mintu P. MD, MAS, Cynthia A. PharmD, MSc, Fran PharmD, Louise MD, MPH, PhD, Steven M. MD, MPH, Thomas M. MD, MS, Gary K. PhD, Anna E. PhD, John S. MD, PhD, Paul D. MD, Preston M. MD, Lucas N. MD, P. Michael MD, PhD,